Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981;6(4):241-8.
doi: 10.1007/BF03189520.

Interactions of some phenylindanedione anticoagulants with human serum albumin

Interactions of some phenylindanedione anticoagulants with human serum albumin

J Paubel et al. Eur J Drug Metab Pharmacokinet. 1981.

Abstract

This study enabled us, to define the quantitative parameters of the interactions which give rise to the formation of complexes between five phenylindanediones and albumin or polymethacryate. The existence of three attachment sites were demonstrated, by which these ligands are bound to the macromolecule. The results from the thermodynamic study of this phenomenon, together with the information supplied by; various spectroscopic methods; the formation of a complex between a synthetic polymer carrying amine functions, and the study of ligands in the presence of surfactant, were all in agreement. Furthermore, a significant correlation between the association constant and physiochemical parameters lipophilic character and acidity was obtained, leading to the conclusion that; the interactions permitting the formation of the complexes between albumin and the five anionic ligands seem to be principally hydrophobic and, to a lesser degree, electrostatic. The latter only occurred in a particular medium at sites which were mainly hydrophobic.

PubMed Disclaimer

Similar articles

References

    1. J Pharm Sci. 1976 Nov;65(11):1673-7 - PubMed
    1. Experientia. 1974 May 15;30(5):460-1 - PubMed
    1. J Biol Chem. 1969 Mar 10;244(5):1303-5 - PubMed
    1. Arch Pharm (Weinheim). 1979 Apr;312(4):295-8 - PubMed
    1. Mol Pharmacol. 1976 Nov;12(6):1052-61 - PubMed

LinkOut - more resources